[PDF][PDF] Solid dispersions: an approach to enhance the bioavailability of poorly water-soluble drugs

SK Das, S Roy, Y Kalimuthu, J Khanam… - International journal of …, 2012 - researchgate.net
Improving oral bioavailability of drugs those given as solid dosage forms remains a
challenge for the formulation scientists due to solubility problems. The dissolution rate could …

[PDF][PDF] Solid dispersions in pharmaceutical technology. Part I. Classification and methods to obtain solid dispersions

B Karolewicz, A Górniak, S Probst, A Owczarek… - Polim …, 2012 - researchgate.net
There are many methods to increase solubility of a substance. These include, inter alia,
preparation of solid dispersions, ie eutectic mixtures, solid solutions, glassy solutions and …

[HTML][HTML] Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions

S Dohrn, C Luebbert, K Lehmkemper… - European Journal of …, 2021 - Elsevier
Understanding the long-term stability of amorphous solid dispersions (ASDs) is important for
their successful approval for market. ASD stability does not only depend on the interplay …

Specific mechanical energy–An essential parameter in the processing of amorphous solid dispersions

SA Thompson, RO Williams III - Advanced Drug Delivery Reviews, 2021 - Elsevier
Specific mechanical energy (SME) is a frequently overlooked but essential parameter of hot-
melt extrusion (HME). It can determine whether an amorphous solid dispersion (ASD) can …

Downstream processing of amorphous solid dispersions into orodispersible tablets

M Kokott, S Klinken, J Breitkreutz, R Wiedey - International Journal of …, 2023 - Elsevier
The formulation development of amorphous solid dispersions (ASDs) towards a patient-
friendly oral solid dosage form is proving to be still challenging. To increase patient's …

Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca

AB Anane-Adjei, E Jacobs, SC Nash, S Askin… - International Journal of …, 2022 - Elsevier
The poor aqueous solubility of many active pharmaceutical ingredients (APIs) dominates
much of the early drug development portfolio and poses a major challenge in …

[HTML][HTML] Production and stability of amorphous solid dispersions produced by a Freeze-drying method from DMSO

E Valkama, O Haluska, VP Lehto, O Korhonen… - International Journal of …, 2021 - Elsevier
Freeze drying is known to be able to produce an amorphous product, but this approach has
been mostly used with water-based media. With APIs which are virtually water insoluble, a …

Amorphous solid dispersions: a robust platform to address bioavailability challenges

A Newman, K Nagapudi, R Wenslow - Therapeutic delivery, 2015 - Taylor & Francis
Amorphous solid dispersions (ASDs) are being used with increasing frequency for poorly
soluble pharmaceutical compounds in development. These systems consist of an …

Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug

JP Lakshman, Y Cao, J Kowalski… - Molecular …, 2008 - ACS Publications
Formulation of active pharmaceutical ingredients (API) in high-energy amorphous forms is a
common strategy to enhance solubility, dissolution rate and, consequently, oral …

Assessing the interrelationship of microstructure, properties, drug release performance, and preparation process for amorphous solid dispersions via noninvasive …

W Jia, PD Yawman, KM Pandya, K Sluga, T Ng… - Pharmaceutical …, 2022 - Springer
Purpose The purpose of this work is to evaluate the interrelationship of microstructure,
properties, and dissolution performance for amorphous solid dispersions (ASDs) prepared …